AstraZeneca PLC (AZN)
75.03
+3.83
(+5.38%)
USD |
NASDAQ |
Apr 25, 16:00
74.26
-0.77
(-1.03%)
After-Hours: 20:00
AstraZeneca Price to Book Value: 5.941 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 24, 2024 | 5.640 |
April 23, 2024 | 5.612 |
April 22, 2024 | 5.555 |
April 19, 2024 | 5.430 |
April 18, 2024 | 5.415 |
April 17, 2024 | 5.428 |
April 16, 2024 | 5.407 |
April 15, 2024 | 5.444 |
April 12, 2024 | 5.460 |
April 11, 2024 | 5.501 |
April 10, 2024 | 5.395 |
April 09, 2024 | 5.418 |
April 08, 2024 | 5.362 |
April 05, 2024 | 5.342 |
April 04, 2024 | 5.334 |
April 03, 2024 | 5.292 |
April 02, 2024 | 5.307 |
April 01, 2024 | 5.327 |
March 28, 2024 | 5.366 |
March 27, 2024 | 5.407 |
March 26, 2024 | 5.254 |
March 25, 2024 | 5.216 |
March 22, 2024 | 5.248 |
March 21, 2024 | 5.243 |
March 20, 2024 | 5.206 |
Date | Value |
---|---|
March 19, 2024 | 5.216 |
March 18, 2024 | 5.216 |
March 15, 2024 | 5.252 |
March 14, 2024 | 5.31 |
March 13, 2024 | 5.353 |
March 12, 2024 | 5.338 |
March 11, 2024 | 5.360 |
March 08, 2024 | 5.267 |
March 07, 2024 | 5.243 |
March 06, 2024 | 5.170 |
March 05, 2024 | 5.133 |
March 04, 2024 | 5.132 |
March 01, 2024 | 5.117 |
February 29, 2024 | 5.082 |
February 28, 2024 | 5.176 |
February 27, 2024 | 5.254 |
February 26, 2024 | 5.222 |
February 23, 2024 | 5.214 |
February 22, 2024 | 5.080 |
February 21, 2024 | 5.156 |
February 20, 2024 | 5.152 |
February 16, 2024 | 5.091 |
February 15, 2024 | 4.977 |
February 14, 2024 | 4.884 |
February 13, 2024 | 4.834 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.211
Minimum
Dec 10 2021
13.47
Maximum
May 13 2020
7.816
Average
6.470
Median
May 17 2023
Price to Book Value Benchmarks
GSK PLC | 4.914 |
Amgen Inc | 23.18 |
Sanofi SA | 1.505 |
Viking Therapeutics Inc | 8.135 |
Fusion Pharmaceuticals Inc | 8.150 |
Price to Book Value Related Metrics
PE Ratio | 39.17 |
PS Ratio | 5.115 |
PEG Ratio | 0.4805 |
Price to Free Cash Flow | 35.68 |
Price | 75.03 |
Earnings Yield | 2.55% |
Market Cap | 232.62B |
PEGY Ratio | 0.4688 |
Operating PE Ratio | 26.87 |
Normalized PE Ratio | 36.74 |